Dr Tomasz Magdziarz is a Senior Scientist with more than 15 years of professional experience in chemo- and bioinformatics. Dr Magdziarz has a strong expertise in developing scientific applications, including data analysis and exploration, programming and documentation and is an expert for building QSAR models and modelling physico-chemical properties and expertise in molecular modelling, including molecular dynamics and docking. Dr Magdziarz also has long-term experience working in private and public projects (small to large-scale).

Dr Christof H. Schwab has a PhD in organic chemistry/chemoinformatics with a long-term expertise in this area regarding its development and application in life sciences, in designing, marketing, and supporting scientific software applications including interaction with customers and end users. Since more than 10 years, Dr Schwab is also active in computational toxicology. Dr Schwab has 20+ years of experience in participating, executing, and managing projects, including large-scale, multi-national, multi-disciplinary public (such as, e.g., ONTOX, eTRANSAFE, iPiE, or eTOX) and private contract research projects.

Dr Oliver Sacher holds a PhD in organic chemistry/chemoinformatics and has long-term expertise in endogenous and exogenous metabolism, in developing scientific applications, including knowledge on databases and database schemas, programming and documentation. Since more than 10 years, Dr Sacher is also active in computational toxicology and has over 15 years of experience in working in private and public projects (small to large-scale).

Dr Chris Barber has a PhD in synthetic organic chemistry and worked at Pfizer for 20 years as a medicinal chemist leading teams to discover new drug candidates across a range of therapeutic areas. Dr Barber moved to Lhasa Limited in 2011 to take the position of Director Science where he led a team of about 50 scientists and cheminformaticians to develop existing and new in silico solutions including databases and predictive models. Dr Barber become the CEO of Lhasa in 2017 and has continued to strengthen Lhasa’s suite of solutions that are now used by >600 member organisations across the world. Dr Barber also has extensive experience of EU-funded projects including eTOX and eTRANSAFE and a passion for finding solutions that support decision-making in chemical safety.